Unlock instant, AI-driven research and patent intelligence for your innovation.

Microneedle devices comprising peptide therapeutics and amino acids and methods of making and using same

A therapeutic agent, amino acid technology, applied in biochemical equipment and methods, medical preparations containing active ingredients, microneedles, etc.

Active Publication Date: 2017-03-08
3M INNOVATIVE PROPERTIES CO
View PDF14 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0005] Microneedle devices with fluid reservoirs and conduits through which therapeutic substances can be delivered to the skin have been proposed, but such systems still present numerous difficulties, such as the ability to fabricate very thin channels that can be reliably used for fluid flow and fees

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Microneedle devices comprising peptide therapeutics and amino acids and methods of making and using same
  • Microneedle devices comprising peptide therapeutics and amino acids and methods of making and using same
  • Microneedle devices comprising peptide therapeutics and amino acids and methods of making and using same

Examples

Experimental program
Comparison scheme
Effect test

example 1

[0170]Sample formulations containing 10 mg / mL of PTH and 12 mg / mL of L-histidine monohydrochloride (His-HCl) in phosphate buffered saline (PBS) were prepared. The pH of the above sample formulations was 5.5-6.0. A control formulation containing 10 mg / mL of PTH in PBS was also prepared. The control formulation did not contain His-HCl. The pH of the control formulation was 6.0. Microneedle arrays were coated with the sample or control formulations described above. Coating was performed by adding 50 μL of the formulation dropwise to the portion of the array defined by the octagonal microneedle pattern. The dip-coated arrays (both sample and control formulations were coated) were dried in an oven at 35°C for approximately 15 hours.

[0171] After drying, the coated arrays were placed in a storage cabinet maintained at 40°C and 96% relative humidity (RH). The PTH content of the coated arrays was determined after storage in the chamber for 1, 3, 7 and 14 days. At indicated tim...

example 2

[0175] The same method as described in Example 1 was used except that the sample formulation contained 12 mg / mL of L-arginine hydrochloride instead of L-histidine monohydrochloride. The pH of the above sample preparation was 6.0. The results are listed in Table 2.

[0176] Table 2 :

[0177]

example 3

[0179] A sample formulation containing 5 mg / mL salmon calcitonin and 12 mg / mL L-histidine monohydrochloride (His-HCl) in PBS was prepared. The pH of the above sample preparation was 5.5. A control formulation containing 5 mg / mL salmon calcitonin in PBS was also prepared. The control formulation did not contain His-HCl. The pH of the control formulation was 6.0-6.5. Microneedle arrays were coated with the sample or control formulations described above. Coating was performed by adding 50 μL of the formulation dropwise to the portion of the array defined by the octagonal microneedle pattern. The dip-coated arrays (both sample and control formulations were coated) were dried in an oven at 35°C for approximately 15 hours.

[0180] After drying, the coated arrays were placed in a storage cabinet maintained at 40°C and 96% relative humidity (RH). The salmon calcitonin content of the coated arrays was determined after storage in the chambers for 1, 3, 7 and 14 days. At indicated...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

PropertyMeasurementUnit
boiling pointaaaaaaaaaa
surface tensionaaaaaaaaaa
surface tensionaaaaaaaaaa
Login to View More

Abstract

Disclosed are medical devices comprising arrays of microneedles and coatings disposed on or within the microneedles, and methods of making such devices. The coating comprises peptide therapeutics and amino acids. Also disclosed are methods of stabilizing peptide therapeutics with amino acids on microneedle arrays. In some cases, both the peptide therapeutic and the amino acid have a net positive charge or both have a net negative charge. In some instances, the peptide therapeutic is histidine.

Description

[0001] Cross References to Related Applications [0002] This application claims priority to US Provisional Application Nos. 61 / 565,247 and 61 / 565,227, filed November 30, 2011, the disclosures of which are incorporated herein by reference in their entirety. Background technique [0003] Transdermal delivery of therapeutic agents, such as drugs, through the skin to local tissues or the systemic circulatory system without piercing the skin, for example using transdermal patches, has been successfully used for a limited number of therapeutic agent molecules. The main barrier for transporting molecules through the skin is the stratum corneum (the outermost layer of the skin). [0004] Devices comprising arrays of relatively small structures, sometimes referred to as microneedles or micropins, have been disclosed for use in connection with the delivery of therapeutic agents and other substances through the skin and other surfaces. Typically the device is pressed against the skin ...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Patents(China)
IPC IPC(8): A61M37/00A61M5/158A61K38/22
CPCA61M37/0015A61K31/4172A61M2037/0023A61M2037/0046A61M2037/0053A61K47/183A61K38/23A61K38/28A61K38/47A61K31/198A61L31/10A61L31/16A61L2300/214A61L2300/252A61K38/225A61K9/0021A61K38/29C12Y302/01007A61K2300/00A61K47/22A61K9/0087
Inventor 张莹珀西·T·芬恩彼得·R·约翰逊
Owner 3M INNOVATIVE PROPERTIES CO